logo-alt.png
Mice Model Market is estimated to be US$ 2.77 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
May 02, 2022 09:52 ET | PMI
Covina, May 02, 2022 (GLOBE NEWSWIRE) -- Chronic diseases are becoming more common, and there is a growing demand for mice models in cancer research to better understand genetics. In addition,...
Taconic Biosciences Models for Life
Taconic Biosciences Adds New Humanized Immune System (HIS) Model to Its Portfolio For Immuno-Oncology Research
January 18, 2022 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the huNOG-EXL EA (Early Access)...
Taconic Biosciences Models for Life
Taconic Biosciences Launches TruIMPORT™ Importation Solution
May 27, 2021 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces a significant enhancement to the Taconic-Cyagen...
Taconic Biosciences Models for Life
Taconic Biosciences Launches New COVID-19 Mouse Model
April 29, 2021 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., April 29, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This...
Taconic Biosciences Models for Life
Taconic Biosciences Expands Scientific Advisory Board
March 15, 2021 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio
January 18, 2021 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
December 03, 2020 09:00 ET | Taconic Biosciences
RENSSELAER, New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences launches critical model for COVID-19 research
October 26, 2020 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces immediate humanized ACE2 mouse model...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Launches Rapid Restart™ Program
May 18, 2020 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., May 18, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Supports Coronavirus Research
March 20, 2020 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts...